Home: For Medical Professionals
 Archives
|
Join our e-mailing list for medical professionals!
Want to get the latest updates on research? We send out periodic updates via email, and do not share your email address. This list is specifically for medical professionals. Join here
|
CTCL Masters Conference 2005
The 2005 CTCL Masters Conference brought together dermatologists and oncologists from around the globe to discuss approaches to CTCL. read more...
|
CTCL Symposium 2004
The Cutaneous Lymphoma Foundation (formerly the Mycosis Fungoides Foundation), in partnership with the International Society for Cutaneous Lymphomas, organized a Cutaneous T-cell Lymphoma (CTCL) Satellite Symposium. The goal of the symposium was to promote awareness, advance patient care and facilitate research in CTCL by providing an annual venue to highlight new physicians and scientists to the field and new advances in the treatment of CTCL.
The second annual CTCL Satellite Symposium was held at the Society of Investigative Dermatology annual meeting, Friday, April 30, 2004, in Providence, Rhode Island. The following pages contain Dr. Narin Apisarnthanrax's presentation from this event. read more...
|
HuMax-CD4 Phase II Results
The following link will take you to Genmab’s webcast of the presentation of the HuMax-CD4 Phase II results given at the Society of Investigative Dermatology Meeting, April, 2004, presented by Dr. Kevin Cooper, Chairman of Dermatology, Case Western University. It is directed to physicians. If patients are interested in viewing this presentation, you are more than welcome. Please be advised that there are clinical pictures in this ten minute presentation.
Go to Genmab webcast (This link will open a new window)
|
CTCL Symposium 2003
The Cutaneous Lymphoma Foundation (formerly the Mycosis Fungoides Foundation) hosted its inaugural cutaneous T-cell lymphoma (CTCL) Symposium on May 1, 2003 in Miami Beach, Florida. The symposium was part of the International Investigative Dermatology (IID) 2003 meeting. The goal of the symposium was to promote awareness, advance patient care and facilitate research in CTCL. The symposium also provided an annual venue to highlight new physicians and scientists to the field and new advances in the treatment of CTCL.
Below are links to the presentations from the CTCL Symposium:
Dr. Lars E. French: T-cell Survival in CTCL
Sam Hwang, M.D., Ph.D.: How do T-Cells Home to Skin?
Stuart R. Lessin, M.D.: Prevention Strategies for CTCL
Karen S. McGinnis, M.D.: Denileukin Diftitox for the Treatment of Panniculitic Lymphoma
|
